Thymol Reduces Acetic Acid-induced Inflammatory Response Through Inhibition of NF-kB Signaling Pathway in Rat Colon Tissue

Overview

Journal Inflammopharmacology

Specialty Pharmacology

Date 2019 Mar 24

PMID 30903350

Citations 26

Authors

Mohsen Chamanara

Alireza Abdollahi

Seyed Mahdi Rezayat

Mamoud Ghazi-Khansari

Ahmadreza Dehpour

Ehsan Nassireslami

Amir Rashidian

Affiliations

Soon will be listed here.

Abstract

Aim: The aim of the present study was to evaluate the anti-inflammatory effect of thymol in acetic acid-induced rat colitis through inhibiting the NF-κB signaling pathway.

Methods: Colitis was induced by intra-rectal administration of 2 mL of diluted acetic acid (4%) solution using a flexible plastic rubber catheter in Wistar rats. Colitis was induced on the first day and all treatments were applied 5 days after the induction of colitis. Thymol was dissolved in 0.2% tween 80 in saline and administered orally at doses of 10, 30, and 100 mg/kg per day. Macroscopic and histopathologic investigations were done. The expression of myeloperoxidase (MPO) and tumor necrosis factor-α (TNF-α) was determined by immunohistochemistry (IHC) assay. The protein expression level of pNF-κB p65 was measured by the Western blot technique.

Results: Treatment with thymol reduced mucosal and histological damages compared to the acetic acid group. Our results showed that thymol markedly inhibited the production of MPO and TNF-α in the colon tissue of the acetic acid-induced group. In addition, thymol decreased acetic acid-induced up-regulation of pNFκB p65 protein.

Conclusions: The results of our study suggest that thymol exerts an anti-inflammatory effect in acetic acid-induced rat colitis by inhibiting the NF-κB signaling pathway and downregulating TNF-α and MPO expressions.

Citing Articles

Ability of short-chain fatty acids to reduce inflammation and attract leucocytes to the inflamed skin of gilthead seabream (Sparus aurata L.).

Albaladejo-Riad N, El Qendouci M, Cuesta A, Esteban M Sci Rep. 2024; 14(1):31404.

PMID: 39732927 PMC: 11682419. DOI: 10.1038/s41598-024-83033-y.

Antioxidant Therapy in Inflammatory Bowel Diseases: How Far Have We Come and How Close Are We?.

Xavier L, Reis T, da Paz Martins A, Santos J, Bueno N, Goulart M Antioxidants (Basel). 2024; 13(11).

PMID: 39594511 PMC: 11590966. DOI: 10.3390/antiox13111369.

Harnessing nature's pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis.

Huang Y, Wu Q, Li S, Lin X, Yang S, Zhu R Front Pharmacol. 2024; 15:1394124.

PMID: 39206263 PMC: 11349575. DOI: 10.3389/fphar.2024.1394124.

Thymol Protects against 5-Fluorouracil-Induced Hepatotoxicity via the Regulation of the Akt/GSK-3β Pathway in In Vivo and In Silico Experimental Models.

Mahran Y, Badr A, Al-Kharashi L, Alajami H, Aldamry N, Bayoumy N Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204199 PMC: 11357534. DOI: 10.3390/ph17081094.

Natural approaches for the management of ulcerative colitis: evidence of preclinical and clinical investigations.

Subudhi R, Poonia N, Singh D, Arora V Nat Prod Bioprospect. 2024; 14(1):42.

PMID: 39078427 PMC: 11289194. DOI: 10.1007/s13659-024-00463-x.

References

Liang D, Li F, Fu Y, Cao Y, Song X, Wang T . Thymol inhibits LPS-stimulated inflammatory response via down-regulation of NF-κB and MAPK signaling pathways in mouse mammary epithelial cells. Inflammation. 2013; 37(1):214-22. DOI: 10.1007/s10753-013-9732-x. View

Deng X, Li H, Chen J, Li R, Qu R, Fu Q . Thymol produces an antidepressant-like effect in a chronic unpredictable mild stress model of depression in mice. Behav Brain Res. 2015; 291:12-19. DOI: 10.1016/j.bbr.2015.04.052. View

Klebanoff S . Myeloperoxidase: friend and foe. J Leukoc Biol. 2005; 77(5):598-625. DOI: 10.1189/jlb.1204697. View

Arijs I, Li K, Toedter G, Quintens R, Van Lommel L, Van Steen K . Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis. Gut. 2009; 58(12):1612-9. DOI: 10.1136/gut.2009.178665. View

Lv J, Zhang Y, Tian Z, Liu F, Shi Y, Liu Y . Astragalus polysaccharides protect against dextran sulfate sodium-induced colitis by inhibiting NF-κВ activation. Int J Biol Macromol. 2017; 98:723-729. DOI: 10.1016/j.ijbiomac.2017.02.024. View

Du X, Chen W, Wang Y, Chen C, Guo L, Ju R . Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation. Int Immunopharmacol. 2017; 45:16-25. DOI: 10.1016/j.intimp.2017.01.015. View

Cheng J, Shah Y, Ma X, Pang X, Tanaka T, Kodama T . Therapeutic role of rifaximin in inflammatory bowel disease: clinical implication of human pregnane X receptor activation. J Pharmacol Exp Ther. 2010; 335(1):32-41. PMC: 2957776. DOI: 10.1124/jpet.110.170225. View

Rezayat S, Dehpour A, Motamed S, Yazdanparast M, Chamanara M, Sahebgharani M . Foeniculum vulgare essential oil ameliorates acetic acid-induced colitis in rats through the inhibition of NF-kB pathway. Inflammopharmacology. 2017; 26(3):851-859. DOI: 10.1007/s10787-017-0409-1. View

Wang Q, Cheng F, Xu Y, Zhang J, Qi J, Liu X . Thymol alleviates lipopolysaccharide-stimulated inflammatory response via downregulation of RhoA-mediated NF-κB signalling pathway in human peritoneal mesothelial cells. Eur J Pharmacol. 2018; 833:210-220. DOI: 10.1016/j.ejphar.2018.06.003. View

10.

Goyal N, Rana A, Ahlawat A, Bijjem K, Kumar P . Animal models of inflammatory bowel disease: a review. Inflammopharmacology. 2014; 22(4):219-33. DOI: 10.1007/s10787-014-0207-y. View

11.

De La Chapa J, Singha P, Lee D, Gonzales C . Thymol inhibits oral squamous cell carcinoma growth via mitochondria-mediated apoptosis. J Oral Pathol Med. 2018; 47(7):674-682. PMC: 6105452. DOI: 10.1111/jop.12735. View

12.

Rashidian A, Muhammadnejad A, Dehpour A, Mehr S, Akhavan M, Shirkoohi R . Atorvastatin attenuates TNBS-induced rat colitis: the involvement of the TLR4/NF-kB signaling pathway. Inflammopharmacology. 2016; 24(2-3):109-18. DOI: 10.1007/s10787-016-0263-6. View

13.

Chamanara M, Rashidian A, Ejtemaei Mehr S, Dehpour A, Shirkohi R, Akbarian R . Melatonin ameliorates TNBS-induced colitis in rats through the melatonin receptors: involvement of TLR4/MyD88/NF-κB signalling pathway. Inflammopharmacology. 2018; 27(2):361-371. DOI: 10.1007/s10787-018-0523-8. View

14.

Mohammadi A, Mahjoub S, Ghafarzadegan K, Nouri H . Immunomodulatory effects of Thymol through modulation of redox status and trace element content in experimental model of asthma. Biomed Pharmacother. 2018; 105:856-861. DOI: 10.1016/j.biopha.2018.05.154. View

15.

Fu Y, Ma J, Shi X, Song X, Yang Y, Xiao S . A novel pyrazole-containing indolizine derivative suppresses NF-κB activation and protects against TNBS-induced colitis via a PPAR-γ-dependent pathway. Biochem Pharmacol. 2017; 135:126-138. DOI: 10.1016/j.bcp.2017.03.013. View

16.

V V, C G . Protective effect of marine mangrove Rhizophora apiculata on acetic acid induced experimental colitis by regulating anti-oxidant enzymes, inflammatory mediators and nuclear factor-kappa B subunits. Int Immunopharmacol. 2013; 18(1):124-34. DOI: 10.1016/j.intimp.2013.11.007. View

17.

Yang J, Li Y, Zhou X, Xu X, Fu Q, Liu C . Two thymol derivatives from the flower buds of Lonicera japonica and their antibacterial activity. Nat Prod Res. 2017; 32(18):2238-2243. DOI: 10.1080/14786419.2017.1371153. View

18.

Triantafyllidis I, Poutahidis T, Taitzoglou I, Kesisoglou I, Lazaridis C, Botsios D . Treatment with Mesna and n-3 polyunsaturated fatty acids ameliorates experimental ulcerative colitis in rats. Int J Exp Pathol. 2016; 96(6):433-43. PMC: 4744821. DOI: 10.1111/iep.12163. View

19.

Siddique I, Khan I . Mechanism of regulation of Na-H exchanger in inflammatory bowel disease: role of TLR-4 signaling mechanism. Dig Dis Sci. 2011; 56(6):1656-62. DOI: 10.1007/s10620-010-1524-7. View

20.

Wang K, Jiang S, Pu T, Fan L, Su F, Ye M . Antifungal activity of phenolic monoterpenes and structure-related compounds against plant pathogenic fungi. Nat Prod Res. 2018; 33(10):1423-1430. DOI: 10.1080/14786419.2017.1419232. View